Why has the synthetic meniscus been called MedTech's "holy grail"? ATRO Medical's new CEO Maarten van der Zanden explains what makes the Artimis artificial meniscus prosthesis different.
Backed by a fresh €3M round, ATRO is now preparing for pivotal studies in the US and Europe. Learn more about the company's ambitious plans in the new episode of our GS MedTech Podcast.
🔗 Learn more about ATRO Medical
🎧 Listen on Spotify